JPMorgan Chase Raises Amrize Price Target to $70

Analysts see potential 13.6% upside for the building materials company's stock.

Mar. 5, 2026 at 9:23pm

Got story updates? Submit your updates here. ›

JPMorgan Chase & Co. has increased its price target for Amrize (NYSE:AMRZ) from $60 to $70, representing a potential upside of 13.6% from the stock's previous close. The firm maintained its "overweight" rating on the building materials company's shares.

Why it matters

The price target increase by a major investment bank signals growing optimism about Amrize's business prospects and future stock performance. This could boost investor confidence and lead to increased buying interest in the company's shares.

The details

In a research report, JPMorgan Chase analysts cited Amrize's strong fundamentals and growth potential as reasons for the price target hike. The company has seen its stock price fluctuate in the $44-$66 range over the past 12 months.

  • The new $70 price target was issued on March 5, 2026.

The players

JPMorgan Chase & Co.

A multinational investment bank and financial services company headquartered in New York City.

Amrize

A Swiss-based company focused on building materials business in North America, operating independently of Holcim AG since June 2025.

Got photos? Submit your photos here. ›

The takeaway

The price target increase by JPMorgan Chase suggests Wall Street sees strong growth potential for Amrize, which could translate to higher stock prices for investors if the company continues to execute well on its business strategy.